NEUE NeueHealth, Inc. revenue, earnings and financials
For the quarter ended June 30, 2025, NeueHealth, Inc. reported revenue of $209M (down 7.5% from a year earlier), net income of −$10.1M and diluted EPS of −$2.62; over the last four quarters revenue was $890M and net income −$81.9M; for the fiscal year ended December 2024 revenue was $937M, down 19.3% on the year before.
NEUE annual revenue and earnings
- Fiscal year ended Dec 2024: revenue $937M, gross profit n/a, operating income −$107M, net income −$135M (margin -14.4%), EPS −$22.65
- Fiscal year ended Dec 2023: revenue $1.16B, gross profit n/a, operating income −$577M, net income −$1.15B (margin -99.2%), EPS −$150.94
- Fiscal year ended Dec 2022: revenue $751M, gross profit n/a, operating income −$369M, net income −$1.46B (margin -193.8%), EPS −$190.04
- Fiscal year ended Dec 2021: revenue $1.51B, gross profit n/a, operating income −$344M, net income −$1.18B (margin -78.3%), EPS −$3.02
NEUE quarterly revenue and earnings
- Quarter ended Jun 30, 2025: revenue $209M (down 7.5% year over year), net income −$10.1M, EPS −$2.62
- Quarter ended Mar 31, 2025: revenue $216M (down 12.0% year over year), net income −$11.7M, EPS −$2.90
- Quarter ended Dec 31, 2024 (from the annual report): revenue $233M (down 20.6% year over year), net income −$2.72M, EPS −$1.96
- Quarter ended Sep 30, 2024: revenue $233M (down 13.5% year over year), net income −$57.4M, EPS −$8.51
- Quarter ended Jun 30, 2024: revenue $226M (down 24.2% year over year), net income −$58.6M, EPS −$8.65
- Quarter ended Mar 31, 2024: revenue $245M (down 18.5% year over year), net income −$15.9M, EPS −$3.53
- Quarter ended Dec 31, 2023 (from the annual report): revenue $293M (down 48.6% year over year), net income −$230M, EPS −$30.53
- Quarter ended Sep 30, 2023: revenue $269M (up 39.3% year over year), net income −$634M, EPS −$81.03
- Quarter ended Jun 30, 2023: revenue $298M (up 99.5% year over year), net income −$113M, EPS −$15.70
- Quarter ended Mar 31, 2023: revenue $301M (down 51.0% year over year), net income −$175M, EPS −$23.68
- Quarter ended Dec 31, 2022 (from the annual report): revenue $569M (up 49.7% year over year), net income −$669M, EPS −$1.08
- Quarter ended Sep 30, 2022: revenue $193M (down 58.4% year over year), net income −$317M, EPS −$41.48
- Quarter ended Jun 30, 2022: revenue $149M (down 64.0% year over year), net income −$275M, EPS −$36.13
- Quarter ended Mar 31, 2022: revenue $613M (up 142.6% year over year), net income −$195M, EPS −$0.32
- Quarter ended Dec 31, 2021 (from the annual report): revenue $380M, net income −$815M, EPS −$1.30
- Quarter ended Sep 30, 2021: revenue $465M, net income −$301M, EPS −$0.47
- Quarter ended Jun 30, 2021: revenue $415M, net income −$44.5M, EPS −$0.28
- Quarter ended Mar 31, 2021: revenue $253M, net income −$25.2M, EPS −$0.18
NEUE cash flow, buybacks and dividends
- Fiscal year ended Dec 2024: operating cash flow −$123M, share buybacks n/a
- Fiscal year ended Dec 2023: operating cash flow −$2.73B, share buybacks n/a
- Fiscal year ended Dec 2022: operating cash flow $234M, share buybacks n/a
- Fiscal year ended Dec 2021: operating cash flow $82.1M, share buybacks n/a
NEUE balance sheet
- Jun 30, 2025: cash $132M, total assets $744M, total liabilities $1.14B, shareholders' equity −$1.37B, long-term debt $212M
- Mar 31, 2025: cash $138M, total assets $896M, total liabilities $1.29B, shareholders' equity −$1.36B, long-term debt $207M
- Dec 31, 2024: cash $83.3M, total assets $544M, total liabilities $930M, shareholders' equity −$1.36B, long-term debt $203M
- Sep 30, 2024: cash $110M, total assets $697M, total liabilities $1.01B, shareholders' equity −$1.35B
- Jun 30, 2024: cash $133M, total assets $897M, total liabilities $1.18B, shareholders' equity −$1.31B
- Mar 31, 2024: cash $113M, total assets $1.11B, total liabilities $1.35B, shareholders' equity −$1.26B
- Dec 31, 2023: cash $87.3M, total assets $1.23B, total liabilities $1.48B, shareholders' equity −$1.26B, long-term debt $66.4M
- Sep 30, 2023: cash $113M, total assets $2.06B, total liabilities $1.86B, shareholders' equity −$1.05B
What is NEUE's revenue?
NeueHealth, Inc. reported $890M of revenue over its last four quarters, through June 30, 2025.
Is NEUE profitable?
No. NeueHealth, Inc. lost $81.9M over the last four quarters.
What is NEUE's EPS?
Diluted earnings per share over the last four quarters were −$15.99; −$2.62 in the latest quarter.